Molecular Target Selection
Molecular Target Selection is the process of identifying and validating specific biomolecules, typically overexpressed or uniquely expressed in diseased cells, that serve as binding sites for targeted radionuclide therapeutics to enable precise delivery of radiation while minimizing off-target effects.
407
Publications
26.5K
Citations
3.5K
Authors
931
Institutions
Publications per year
2017–2026
132
407
FXR is a molecular target for the effects of vertical sleeve gastrectomy
Karen K. Ryan, Valentina Tremaroli, Christoffer Clemmensen et al. · Nature · 2014 · 919 citations
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Steven J. Kridel, Fumiko Axelrod, Natasha Rozenkrantz et al. · Cancer Research · 2004 · 601 citations · Full text
Medicine, Oncology, Pharmacology +16
1–5 of 407
3.5K
Durban University of Technology, South Africa
4 publications · 155 citations
4
h-index
4
h-index
Durban University of Technology, South Africa
4 publications · 160 citations
4
h-index
4
h-index
4
h-index
1–5 of 3.5K
931
The University of Tokyo
Tokyo, Japan
13 h-index
72 publications
7.7K citations
National Cancer Institute
Bethesda, United States
10 h-index
27 publications
2.1K citations
Harvard University
Cambridge, United States
9 h-index
50 publications
5.8K citations
The University of Texas MD Anderson Cancer Center
Houston, United States
9 h-index
23 publications
1.4K citations
Stanford University
Stanford, United States
8 h-index
19 publications
377 citations
The University of Texas Southwestern Medical Center
Dallas, United States
6 h-index
51 publications
2K citations

University of Milan
Milan, Italy
6 h-index
22 publications
963 citations

Chinese Academy of Sciences
Beijing, China
6 h-index
45 publications
3.3K citations
1–8 of 931
22 publications · 1.8K citations
19
h-index
Repository · 20 publications · 1.5K citations
17
h-index
14 publications · 879 citations
14
h-index
13 publications · 2.1K citations
13
h-index
PNAS · 7 publications · 682 citations
7
h-index
1–5